Company
Science
Products
Animals
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
메뉴를 선택하세요.
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
Contact Us
(R&D)Scientists
Patients-Farm Animal
Patients-Companion Animal
Medical Professionals
IR
News
Events
Report
Jobs
Jobs
Search
Search
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
CLOSE
R & D
Patients
Veterinarians
IR
Jobs
Company
People
Milestones
Collaboration
Location
Science
Research Area
Technology
Scientific Publication
Products
Farm Animal
Companion Animal
Pipeline
Animals
Farm Animal
Companion Animal
News
> IR > News
News
Events
Report
제목
PLS-ASF 아프리카돼지열병DNA백신, 목적동물 첫번째 챌린지에서 유효성 확인
작성자
관리자
등록일
21-04-09
조회수
4,597
플럼라인생명과학이 개발중인 아프리카돼지열병(ASF)DNA백신 후보물질 'PLS-ASF'(이하 DNA백신)를
돼지농장에서 1차 실험(챌린지)한 결과 새끼돼지(자돈)의 생존률이 66%를 기록했다고 지난 2020년 12월 7일 밝혔다.
https://news.mt.co.kr/mtview.php?no=2020120706091018924
목록
공지사항
이전글
플럼라인생명과학, IPO 대표주관사 유진투자증권으로 변경
공지사항
다음글
특허권 취득(구제역 바이러스 A형 백신 조성물)